Cargando…
The Quest for Anti-α-Synuclein Antibody Specificity—Lessons Learnt From Flow Cytometry Analysis
The accumulation of alpha-synuclein (aSyn) is the hallmark of a group of neurodegenerative conditions termed synucleopathies. Physiological functions of aSyn, including those outside of the CNS, remain elusive. However, a reliable and reproducible evaluation of aSyn protein expression in different c...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334871/ https://www.ncbi.nlm.nih.gov/pubmed/35911883 http://dx.doi.org/10.3389/fneur.2022.869103 |
_version_ | 1784759201901314048 |
---|---|
author | Leupold, Lukas Sigutova, Veronika Gerasimova, Elizaveta Regensburger, Martin Zundler, Sebastian Zunke, Friederike Xiang, Wei Winner, Beate Prots, Iryna |
author_facet | Leupold, Lukas Sigutova, Veronika Gerasimova, Elizaveta Regensburger, Martin Zundler, Sebastian Zunke, Friederike Xiang, Wei Winner, Beate Prots, Iryna |
author_sort | Leupold, Lukas |
collection | PubMed |
description | The accumulation of alpha-synuclein (aSyn) is the hallmark of a group of neurodegenerative conditions termed synucleopathies. Physiological functions of aSyn, including those outside of the CNS, remain elusive. However, a reliable and reproducible evaluation of aSyn protein expression in different cell types and especially in low-expressing cells is impeded by the existence of a huge variety of poorly characterized anti-aSyn antibodies and a lack of a routinely used sensitive detection methods. Here, we developed a robust flow cytometry-based workflow for aSyn detection and antibody validation. We test our workflow using three commercially available antibodies (MJFR1, LB509, and 2A7) in a variety of human cell types, including induced pluripotent stem cells, T lymphocytes, and fibroblasts, and provide a cell- and antibody-specific map for aSyn expression. Strikingly, we demonstrate a previously unobserved unspecificity of the LB509 antibody, while the MJFR1 clone revealed specific aSyn binding however with low sensitivity. On the other hand, we identified an aSyn-specific antibody clone 2A7 with an optimal sensitivity for detecting aSyn in a range of cell types, including those with low aSyn expression. We further utilize our workflow to demonstrate the ability of the 2A7 antibody to distinguish between physiological differences in aSyn expression in neuronal and non-neuronal cells from the cortical organoids, and in neural progenitors and midbrain dopaminergic neurons from healthy controls and in patients with Parkinson's disease who have aSyn gene locus duplication. Our results provide a proof of principle for the use of high-throughput flow cytometry-based analysis of aSyn and highlight the necessity of rigorous aSyn antibody validation to facilitate the research of aSyn physiology and pathology. |
format | Online Article Text |
id | pubmed-9334871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93348712022-07-30 The Quest for Anti-α-Synuclein Antibody Specificity—Lessons Learnt From Flow Cytometry Analysis Leupold, Lukas Sigutova, Veronika Gerasimova, Elizaveta Regensburger, Martin Zundler, Sebastian Zunke, Friederike Xiang, Wei Winner, Beate Prots, Iryna Front Neurol Neurology The accumulation of alpha-synuclein (aSyn) is the hallmark of a group of neurodegenerative conditions termed synucleopathies. Physiological functions of aSyn, including those outside of the CNS, remain elusive. However, a reliable and reproducible evaluation of aSyn protein expression in different cell types and especially in low-expressing cells is impeded by the existence of a huge variety of poorly characterized anti-aSyn antibodies and a lack of a routinely used sensitive detection methods. Here, we developed a robust flow cytometry-based workflow for aSyn detection and antibody validation. We test our workflow using three commercially available antibodies (MJFR1, LB509, and 2A7) in a variety of human cell types, including induced pluripotent stem cells, T lymphocytes, and fibroblasts, and provide a cell- and antibody-specific map for aSyn expression. Strikingly, we demonstrate a previously unobserved unspecificity of the LB509 antibody, while the MJFR1 clone revealed specific aSyn binding however with low sensitivity. On the other hand, we identified an aSyn-specific antibody clone 2A7 with an optimal sensitivity for detecting aSyn in a range of cell types, including those with low aSyn expression. We further utilize our workflow to demonstrate the ability of the 2A7 antibody to distinguish between physiological differences in aSyn expression in neuronal and non-neuronal cells from the cortical organoids, and in neural progenitors and midbrain dopaminergic neurons from healthy controls and in patients with Parkinson's disease who have aSyn gene locus duplication. Our results provide a proof of principle for the use of high-throughput flow cytometry-based analysis of aSyn and highlight the necessity of rigorous aSyn antibody validation to facilitate the research of aSyn physiology and pathology. Frontiers Media S.A. 2022-07-15 /pmc/articles/PMC9334871/ /pubmed/35911883 http://dx.doi.org/10.3389/fneur.2022.869103 Text en Copyright © 2022 Leupold, Sigutova, Gerasimova, Regensburger, Zundler, Zunke, Xiang, Winner and Prots. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Leupold, Lukas Sigutova, Veronika Gerasimova, Elizaveta Regensburger, Martin Zundler, Sebastian Zunke, Friederike Xiang, Wei Winner, Beate Prots, Iryna The Quest for Anti-α-Synuclein Antibody Specificity—Lessons Learnt From Flow Cytometry Analysis |
title | The Quest for Anti-α-Synuclein Antibody Specificity—Lessons Learnt From Flow Cytometry Analysis |
title_full | The Quest for Anti-α-Synuclein Antibody Specificity—Lessons Learnt From Flow Cytometry Analysis |
title_fullStr | The Quest for Anti-α-Synuclein Antibody Specificity—Lessons Learnt From Flow Cytometry Analysis |
title_full_unstemmed | The Quest for Anti-α-Synuclein Antibody Specificity—Lessons Learnt From Flow Cytometry Analysis |
title_short | The Quest for Anti-α-Synuclein Antibody Specificity—Lessons Learnt From Flow Cytometry Analysis |
title_sort | quest for anti-α-synuclein antibody specificity—lessons learnt from flow cytometry analysis |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334871/ https://www.ncbi.nlm.nih.gov/pubmed/35911883 http://dx.doi.org/10.3389/fneur.2022.869103 |
work_keys_str_mv | AT leupoldlukas thequestforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT sigutovaveronika thequestforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT gerasimovaelizaveta thequestforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT regensburgermartin thequestforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT zundlersebastian thequestforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT zunkefriederike thequestforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT xiangwei thequestforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT winnerbeate thequestforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT protsiryna thequestforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT leupoldlukas questforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT sigutovaveronika questforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT gerasimovaelizaveta questforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT regensburgermartin questforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT zundlersebastian questforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT zunkefriederike questforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT xiangwei questforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT winnerbeate questforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis AT protsiryna questforantiasynucleinantibodyspecificitylessonslearntfromflowcytometryanalysis |